Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Understanding Dexmedetomidine in Neonates After Open Heart Surgery
The Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Neonates Following Open Heart Surgery
Status: Enrolling
Updated:  2/12/2010
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Understanding Dexmedetomidine in Neonates After Open Heart Surgery
The Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Neonates Following Open Heart Surgery
Status: Enrolling
Updated: 2/12/2010
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety Study of Allogeneic Mesenchymal Precursor Cells (MPCs) in Subjects With Recent Acute Myocardial Infarction
A Phase 1b/2a Dose Escalation Study to Assess the Safety and Feasibility of Transendocardial Delivery of 3 Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs) in Subjects With Recent Acute Myocardial Infarction
Status: Enrolling
Updated:  2/16/2010
University of Minnesota/Minneapolis Heart Institute
mi
from
Minneapolis, MN
Safety Study of Allogeneic Mesenchymal Precursor Cells (MPCs) in Subjects With Recent Acute Myocardial Infarction
A Phase 1b/2a Dose Escalation Study to Assess the Safety and Feasibility of Transendocardial Delivery of 3 Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs) in Subjects With Recent Acute Myocardial Infarction
Status: Enrolling
Updated: 2/16/2010
University of Minnesota/Minneapolis Heart Institute
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Safety Study of Allogeneic Mesenchymal Precursor Cells (MPCs) in Subjects With Recent Acute Myocardial Infarction
A Phase 1b/2a Dose Escalation Study to Assess the Safety and Feasibility of Transendocardial Delivery of 3 Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs) in Subjects With Recent Acute Myocardial Infarction
Status: Enrolling
Updated:  2/16/2010
Texas Heart Institute/St. Luke's Hospital
mi
from
Houston, TX
Safety Study of Allogeneic Mesenchymal Precursor Cells (MPCs) in Subjects With Recent Acute Myocardial Infarction
A Phase 1b/2a Dose Escalation Study to Assess the Safety and Feasibility of Transendocardial Delivery of 3 Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs) in Subjects With Recent Acute Myocardial Infarction
Status: Enrolling
Updated: 2/16/2010
Texas Heart Institute/St. Luke's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
The Saint Francis Remote Ischemic Preconditioning Trial (SaFR)
The Saint Francis Remote Ischemic Preconditioning Trial (SaFR)
Status: Enrolling
Updated:  3/1/2010
St. Francis Hospital-The Heart Center
mi
from
Roslyn, NY
The Saint Francis Remote Ischemic Preconditioning Trial (SaFR)
The Saint Francis Remote Ischemic Preconditioning Trial (SaFR)
Status: Enrolling
Updated: 3/1/2010
St. Francis Hospital-The Heart Center
mi
from
Roslyn, NY
Click here to add this to my saved trials
Effects of Omega-3 Fatty Acids on Platelets in Patients With Coronary Artery Disease With Hypertriglyceridemia
Effects of Prescription OMega-3 Fatty Acids (Omacor®, Lovaza®) on Platelet Activity in Patients With Coronary Artery Disease With Hypertriglyceridemia (OMPA-CAD)
Status: Enrolling
Updated:  3/11/2010
Victor Serebruany
mi
from
Towson, MD
Effects of Omega-3 Fatty Acids on Platelets in Patients With Coronary Artery Disease With Hypertriglyceridemia
Effects of Prescription OMega-3 Fatty Acids (Omacor®, Lovaza®) on Platelet Activity in Patients With Coronary Artery Disease With Hypertriglyceridemia (OMPA-CAD)
Status: Enrolling
Updated: 3/11/2010
Victor Serebruany
mi
from
Towson, MD
Click here to add this to my saved trials
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated:  3/29/2010
Retina Vitreous Associates
mi
from
Beverly Hills, CA
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated: 3/29/2010
Retina Vitreous Associates
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated:  3/29/2010
University of California San Diego
mi
from
LaJolla, CA
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated: 3/29/2010
University of California San Diego
mi
from
LaJolla, CA
Click here to add this to my saved trials
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated:  3/29/2010
Doheny Eye Institute
mi
from
Los Angeles, CA
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated: 3/29/2010
Doheny Eye Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated:  3/29/2010
East Bay Retina Institute
mi
from
Oakland, CA
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated: 3/29/2010
East Bay Retina Institute
mi
from
Oakland, CA
Click here to add this to my saved trials
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated:  3/29/2010
Retina Macula Institute
mi
from
Torrance, CA
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated: 3/29/2010
Retina Macula Institute
mi
from
Torrance, CA
Click here to add this to my saved trials
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated:  3/29/2010
Retina Group of Florida
mi
from
Fort Lauderdale, FL
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated: 3/29/2010
Retina Group of Florida
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated:  3/29/2010
Retina Institute of Hawai'i
mi
from
Honolulu, HI
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated: 3/29/2010
Retina Institute of Hawai'i
mi
from
Honolulu, HI
Click here to add this to my saved trials
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated:  3/29/2010
Illinois Retina Associates
mi
from
Joliet, IL
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated: 3/29/2010
Illinois Retina Associates
mi
from
Joliet, IL
Click here to add this to my saved trials
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated:  3/29/2010
University of Kansas
mi
from
Prairie Village, KA
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated: 3/29/2010
University of Kansas
mi
from
Prairie Village, KA
Click here to add this to my saved trials
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated:  3/29/2010
Johns Hopkins University Wilmer Eye Institute
mi
from
Baltimore, MD
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated: 3/29/2010
Johns Hopkins University Wilmer Eye Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated:  3/29/2010
Eye Care Specialists
mi
from
Kingston, PA
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated: 3/29/2010
Eye Care Specialists
mi
from
Kingston, PA
Click here to add this to my saved trials
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated:  3/29/2010
Black Hills Eye Institute
mi
from
Rapid City, SD
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated: 3/29/2010
Black Hills Eye Institute
mi
from
Rapid City, SD
Click here to add this to my saved trials
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated:  3/29/2010
Texas Retina Associates
mi
from
Arlington, TX
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Status: Enrolling
Updated: 3/29/2010
Texas Retina Associates
mi
from
Arlington, TX
Click here to add this to my saved trials
Validation of Minimally Invasive Ultrasound Indicator Dilution Technique in Critically Ill Children
Validation of a Novel, Minimally Invasive Ultrasound Indicator Dilution Technique for Measuring Cardiac Index in Critically Ill Children
Status: Enrolling
Updated:  4/9/2010
Children's Hospital Boston
mi
from
Boston, MA
Validation of Minimally Invasive Ultrasound Indicator Dilution Technique in Critically Ill Children
Validation of a Novel, Minimally Invasive Ultrasound Indicator Dilution Technique for Measuring Cardiac Index in Critically Ill Children
Status: Enrolling
Updated: 4/9/2010
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Aetna_Intel Medicare Home Biomonitoring Study
Study of Impact of Home Biomonitoring With Nurse Case Manager Support for a Congestive Heart Failure Cohort, Compared to Case Manager Support Without Biomonitoring
Status: Enrolling
Updated:  4/15/2010
Aetna
mi
from
Princeton, NJ
Aetna_Intel Medicare Home Biomonitoring Study
Study of Impact of Home Biomonitoring With Nurse Case Manager Support for a Congestive Heart Failure Cohort, Compared to Case Manager Support Without Biomonitoring
Status: Enrolling
Updated: 4/15/2010
Aetna
mi
from
Princeton, NJ
Click here to add this to my saved trials
Global and Regional Myocardial Strain and Power Output In Patients With Single Ventricles Using Novel MRI Techniques
Global and Regional Myocardial Strain and Power Output In Patients With Single Ventricles Using Novel MRI Techniques
Status: Enrolling
Updated:  4/20/2010
University of California, San-Francisco
mi
from
San-Francisco, CA
Global and Regional Myocardial Strain and Power Output In Patients With Single Ventricles Using Novel MRI Techniques
Global and Regional Myocardial Strain and Power Output In Patients With Single Ventricles Using Novel MRI Techniques
Status: Enrolling
Updated: 4/20/2010
University of California, San-Francisco
mi
from
San-Francisco, CA
Click here to add this to my saved trials
The Effect of GHRH Therapy on Myocardial Structure and Function in Congestive Heart Failure
The Effect of GHRH Therapy on Myocardial Structure and Function in Congestive Heart Failure
Status: Enrolling
Updated:  4/30/2010
Massachusetts General Hospital/ Geriatric Research
mi
from
Boston, MA
The Effect of GHRH Therapy on Myocardial Structure and Function in Congestive Heart Failure
The Effect of GHRH Therapy on Myocardial Structure and Function in Congestive Heart Failure
Status: Enrolling
Updated: 4/30/2010
Massachusetts General Hospital/ Geriatric Research
mi
from
Boston, MA
Click here to add this to my saved trials
Rho Kinase (ROCK) Inhibition in Carotid Atherosclerosis
The Effect of Fasudil on Rho Kinase Activity in Patients Scheduled for Elective Carotid Endarterectomy
Status: Enrolling
Updated:  5/3/2010
Brigham and Women's Hosp
mi
from
Boston, MA
Rho Kinase (ROCK) Inhibition in Carotid Atherosclerosis
The Effect of Fasudil on Rho Kinase Activity in Patients Scheduled for Elective Carotid Endarterectomy
Status: Enrolling
Updated: 5/3/2010
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Dopamine in Acute Decompensated Heart Failure II
Comparison of High-dose Furosemide, Low-dose Furosemide, and the Combination of Low-dose Furosemide and Low-dose Dopamine in Patients With Acute Decompensated Heart Failure
Status: Enrolling
Updated:  5/25/2010
Division of Cardiology, Emory University Hospital
mi
from
Atlanta, GA
Dopamine in Acute Decompensated Heart Failure II
Comparison of High-dose Furosemide, Low-dose Furosemide, and the Combination of Low-dose Furosemide and Low-dose Dopamine in Patients With Acute Decompensated Heart Failure
Status: Enrolling
Updated: 5/25/2010
Division of Cardiology, Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Dopamine in Acute Decompensated Heart Failure II
Comparison of High-dose Furosemide, Low-dose Furosemide, and the Combination of Low-dose Furosemide and Low-dose Dopamine in Patients With Acute Decompensated Heart Failure
Status: Enrolling
Updated:  5/25/2010
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Dopamine in Acute Decompensated Heart Failure II
Comparison of High-dose Furosemide, Low-dose Furosemide, and the Combination of Low-dose Furosemide and Low-dose Dopamine in Patients With Acute Decompensated Heart Failure
Status: Enrolling
Updated: 5/25/2010
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Global Vascular Effects of Intermittent Pneumatic Compression-Pilot Study
Global Vascular Effects of Intermittent Pneumatic Compression-Pilot Study
Status: Enrolling
Updated:  5/27/2010
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Global Vascular Effects of Intermittent Pneumatic Compression-Pilot Study
Global Vascular Effects of Intermittent Pneumatic Compression-Pilot Study
Status: Enrolling
Updated: 5/27/2010
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Detection of Left Atrial Appendage (LAA) Thrombus: Comparison of Cardiac Magnetic Resonance Imaging and Transesophageal Echocardiogram
Detection of Left Atrial Appendage Thrombus in Patients Referred For Cardioversion: Comparative Analysis of Cardiac Magnetic Resonance Imaging and Transesophageal Echocardiogram
Status: Enrolling
Updated:  6/21/2010
Gundersen Lutheran Health System
mi
from
La Crosse, WI
Detection of Left Atrial Appendage (LAA) Thrombus: Comparison of Cardiac Magnetic Resonance Imaging and Transesophageal Echocardiogram
Detection of Left Atrial Appendage Thrombus in Patients Referred For Cardioversion: Comparative Analysis of Cardiac Magnetic Resonance Imaging and Transesophageal Echocardiogram
Status: Enrolling
Updated: 6/21/2010
Gundersen Lutheran Health System
mi
from
La Crosse, WI
Click here to add this to my saved trials
Vascular and Neuro-inflammatory Effects of Endurance Exercise Training in African Americans
Vascular and Neuro-inflammatory Effects of Endurance Exercise Training in African Americans
Status: Enrolling
Updated:  6/23/2010
Kinesiology and Community Health Department, University of Illinois at Urbana-Champaign
mi
from
Urbana, IL
Vascular and Neuro-inflammatory Effects of Endurance Exercise Training in African Americans
Vascular and Neuro-inflammatory Effects of Endurance Exercise Training in African Americans
Status: Enrolling
Updated: 6/23/2010
Kinesiology and Community Health Department, University of Illinois at Urbana-Champaign
mi
from
Urbana, IL
Click here to add this to my saved trials
Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis
Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis
Status: Enrolling
Updated:  6/24/2010
University of Michigan Dialysis Center
mi
from
Ann Arbor, MI
Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis
Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis
Status: Enrolling
Updated: 6/24/2010
University of Michigan Dialysis Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis
Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis
Status: Enrolling
Updated:  6/24/2010
University of Michigan Dialysis Center
mi
from
Livonia, MI
Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis
Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis
Status: Enrolling
Updated: 6/24/2010
University of Michigan Dialysis Center
mi
from
Livonia, MI
Click here to add this to my saved trials
Trial of Vasopressin and Epinephrine to Epinephrine Only for In-Hospital Pediatric Cardiopulmonary Resuscitation
A Prospective, Randomized, Controlled Trial of Combination Vasopressin and Epinephrine to Epinephrine Only for In-Intensive Care Unit Pediatric Cardiopulmonary Resuscitation
Status: Enrolling
Updated:  6/24/2010
Universtity of Texas Southwestern, Children's Medical Center
mi
from
Dallas, TX
Trial of Vasopressin and Epinephrine to Epinephrine Only for In-Hospital Pediatric Cardiopulmonary Resuscitation
A Prospective, Randomized, Controlled Trial of Combination Vasopressin and Epinephrine to Epinephrine Only for In-Intensive Care Unit Pediatric Cardiopulmonary Resuscitation
Status: Enrolling
Updated: 6/24/2010
Universtity of Texas Southwestern, Children's Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Brain, Gut and Kidney Blood Flow During Medical Closure of PDA
Comparison of Cerebral, Renal and Mesenteric Perfusion Using Near Infrared Spectroscopy in Neonates During Patent Ductus Arteriosus Closure With Ibuprofen or Indomethacin.
Status: Enrolling
Updated:  6/25/2010
Kosair Children's Hospital
mi
from
Lousiville, KY
Brain, Gut and Kidney Blood Flow During Medical Closure of PDA
Comparison of Cerebral, Renal and Mesenteric Perfusion Using Near Infrared Spectroscopy in Neonates During Patent Ductus Arteriosus Closure With Ibuprofen or Indomethacin.
Status: Enrolling
Updated: 6/25/2010
Kosair Children's Hospital
mi
from
Lousiville, KY
Click here to add this to my saved trials
Aleskiren Effect on Plaque Progression Using 3-dimensional Magnetic Resonance Imaging (3D MRI)
Aliskerin Effect on Plaque Progression in Established Atherosclerosis Using High Resolution 3D MRI: A Double Blind Placebo Controlled Trial
Status: Enrolling
Updated:  7/16/2010
OSU Davis Heart and Lung Research Institute
mi
from
Columbus, OH
Aleskiren Effect on Plaque Progression Using 3-dimensional Magnetic Resonance Imaging (3D MRI)
Aliskerin Effect on Plaque Progression in Established Atherosclerosis Using High Resolution 3D MRI: A Double Blind Placebo Controlled Trial
Status: Enrolling
Updated: 7/16/2010
OSU Davis Heart and Lung Research Institute
mi
from
Columbus, OH
Click here to add this to my saved trials
Exercise Study Including Patients With Hypertrophic Cardiomyopathy
A Randomized Trial of Moderate Intensity Exercise Training in Patients With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated:  7/19/2010
Stanford University School of Medicine
mi
from
Stanford, CA
Exercise Study Including Patients With Hypertrophic Cardiomyopathy
A Randomized Trial of Moderate Intensity Exercise Training in Patients With Hypertrophic Cardiomyopathy
Status: Enrolling
Updated: 7/19/2010
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis
A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis
Status: Enrolling
Updated:  7/21/2010
Prairie Education and Research Cooperative
mi
from
Springfield, IL
A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis
A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis
Status: Enrolling
Updated: 7/21/2010
Prairie Education and Research Cooperative
mi
from
Springfield, IL
Click here to add this to my saved trials
Inflammation and Vascular Function in Atherosclerosis
Inflammation and Vascular Function in Atherosclerosis
Status: Enrolling
Updated:  7/22/2010
Brigham and Women's Hosp
mi
from
Boston, MA
Inflammation and Vascular Function in Atherosclerosis
Inflammation and Vascular Function in Atherosclerosis
Status: Enrolling
Updated: 7/22/2010
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Improving Door-to-Balloon Time in STEMI
Emergency Department Physician Activation of the Catheterization Laboratory and Immediate Transfer to an Immediately Available Catheterization Lab Reduce Door-to-Balloon Time in ST-Elevation Myocardial Infarction
Status: Enrolling
Updated:  7/22/2010
St. Francis Heart Center
mi
from
Indianapolis, IN
Improving Door-to-Balloon Time in STEMI
Emergency Department Physician Activation of the Catheterization Laboratory and Immediate Transfer to an Immediately Available Catheterization Lab Reduce Door-to-Balloon Time in ST-Elevation Myocardial Infarction
Status: Enrolling
Updated: 7/22/2010
St. Francis Heart Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Evaluation Cardiac Function With Echo and BNP in Obstetrical Patients With/Without Cardiac Disease
Prospective Cohort Evaluation of Cardiac Function With Echocardiography and Serum B-type Natriuretic Peptide (BNP) in Obstetrical Patients With and Without a History of Cardiac Disease
Status: Enrolling
Updated:  8/4/2010
Regional Perinatal Center
mi
from
Syracuse, NY
Evaluation Cardiac Function With Echo and BNP in Obstetrical Patients With/Without Cardiac Disease
Prospective Cohort Evaluation of Cardiac Function With Echocardiography and Serum B-type Natriuretic Peptide (BNP) in Obstetrical Patients With and Without a History of Cardiac Disease
Status: Enrolling
Updated: 8/4/2010
Regional Perinatal Center
mi
from
Syracuse, NY
Click here to add this to my saved trials
Evaluation Cardiac Function With Echo and BNP in Obstetrical Patients With/Without Cardiac Disease
Prospective Cohort Evaluation of Cardiac Function With Echocardiography and Serum B-type Natriuretic Peptide (BNP) in Obstetrical Patients With and Without a History of Cardiac Disease
Status: Enrolling
Updated:  8/4/2010
Cardiology Associates Central New York Physician Office Building
mi
from
Syracuse, NY
Evaluation Cardiac Function With Echo and BNP in Obstetrical Patients With/Without Cardiac Disease
Prospective Cohort Evaluation of Cardiac Function With Echocardiography and Serum B-type Natriuretic Peptide (BNP) in Obstetrical Patients With and Without a History of Cardiac Disease
Status: Enrolling
Updated: 8/4/2010
Cardiology Associates Central New York Physician Office Building
mi
from
Syracuse, NY
Click here to add this to my saved trials
Effect of Prontosan Wound Irrigation Solution on Venous Ulcers
Randomised, Controlled, Clinical Trial on the Safety and Efficacy of Prontosan Wound Irrigation Solution Compared to Standard Therapy in the Treatment of Hard-to-Heal Venous Leg Ulcers
Status: Enrolling
Updated:  8/16/2010
Calvary hospital center for curative and palliative wound care
mi
from
Bronx, NY
Effect of Prontosan Wound Irrigation Solution on Venous Ulcers
Randomised, Controlled, Clinical Trial on the Safety and Efficacy of Prontosan Wound Irrigation Solution Compared to Standard Therapy in the Treatment of Hard-to-Heal Venous Leg Ulcers
Status: Enrolling
Updated: 8/16/2010
Calvary hospital center for curative and palliative wound care
mi
from
Bronx, NY
Click here to add this to my saved trials
Sodium Channel Splicing in Heart Failure Trial
Sodium Channel Splicing in Heart Failure Trial
Status: Enrolling
Updated:  8/19/2010
University of Illinois at Chicago
mi
from
Chicago, IL
Sodium Channel Splicing in Heart Failure Trial
Sodium Channel Splicing in Heart Failure Trial
Status: Enrolling
Updated: 8/19/2010
University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Sodium Channel Splicing in Heart Failure Trial
Sodium Channel Splicing in Heart Failure Trial
Status: Enrolling
Updated:  8/19/2010
Jesse Brown VA Medical Center
mi
from
Chicago, IL
Sodium Channel Splicing in Heart Failure Trial
Sodium Channel Splicing in Heart Failure Trial
Status: Enrolling
Updated: 8/19/2010
Jesse Brown VA Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Cardiology PC
mi
from
Birmingham, AL
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Cardiology PC
mi
from
Birmingham, AL
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Arizona Heart Institute
mi
from
Phoenix, AZ
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Arizona Heart Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Mayo Clinic Hospital
mi
from
Phoenix, AZ
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Mayo Clinic Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Scripps Green Hospital / Scripps Clinical Hospital
mi
from
La Jolla, CA
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Scripps Green Hospital / Scripps Clinical Hospital
mi
from
La Jolla, CA
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Stanford Hospitals and Clinics
mi
from
Stanford, CA
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Stanford Hospitals and Clinics
mi
from
Stanford, CA
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
MedStar Washington Hospital Center
mi
from
Washington,
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
Holy Cross Hospital
mi
from
Ft. Lauderdale, FL
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
Holy Cross Hospital
mi
from
Ft. Lauderdale, FL
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated:  9/1/2010
University of Florida
mi
from
Gainesville, FL
ACT34-CMI -- Adult Autologous CD34+ Stem Cells
A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
Status: Enrolling
Updated: 9/1/2010
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials